Back to dashboard
CommercialCoverageLow impact

08.02.06b, Tofersen (Qalsody®)

Independence Blue Cross·Neurology·Pharmacy
Effective date
Jan 1, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

IBX updated their coverage and reimbursement policy for Tofersen (Qalsody®), a specialty pharmacy medication. The policy change affects how this drug will be covered or reimbursed starting January 1, 2025.

Action Required

Action needed
By January 1, 2025: Billing team should review the updated IBX policy for Tofersen (Qalsody®) at the provided URL to understand new coverage or reimbursement requirements. Update any prior authorization processes or billing procedures for this specialty medication if prescribed by providers.

Related policy hubs